Search is Powered by Google
Pharma Industry / Biotech Industry News

Farm Bill's New Tax Credit For Biofuel Production Will Support Development Of Advanced Low-Carbon Biofuels

Main Category: Pharma Industry / Biotech Industry
Article Date: 22 May 2008 - 5:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

The Farm Bill's new Credit for Production of Cellulosic Biofuel provides an important incentive for commercialization of second- and third-generation cellulosic biofuels. The Biotechnology Industry Organization (BIO) urged Congress to override President Bush's veto.

"The farm bill supports acceleration of commercialization that will help make advanced biofuel technology cost-competitive with mature fuel production technologies in the near future," said Brent Erickson, executive vice president of BIO's Industrial & Environmental Section. "Industrial biotechnology companies are developing advanced cellulosic biofuels such as cellulosic ethanol, biobutanol and biobased hydrocarbons. These low-carbon biofuels are made from non-food feedstocks and can directly replace gasoline in transportation fuels, including jet fuel, using the same distribution infrastructure currently in place. The new Credit for Production of Cellulosic Biofuel will encourage companies to move forward as rapidly as possible to build commercial-scale biorefineries and begin producing these new biofuels for consumers."

The Farm Bill includes a new, temporary production tax credit for up to $1.01 per gallon, available through December 31, 2012, with an estimated cost of $403 million over the ten-year budget window.

The Advanced Biofuels & Climate Change Information Center presents the latest commentary and data on the environmental and other impacts of biofuel production. Drop in and add your comments, at http://biofuelsandclimate.wordpress.com.

Upcoming BIO Events

BIO International Convention
June 17-20, 2008
San Diego, CA

Pacific Rim Summit on Industrial Biotechnology and Bioenergy
Sept. 10-12, 2008
Vancouver, BC

About BIO

BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.

http://www.bio.org




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Diabetes Schizophrenia

add medical news today to your facebook

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader

customize your homepage


These are the most read articles from this news category for the last 6 months:
Top Article Star
U.S. FDA Approves Requip® XL™, The First And Only Oral Once-daily Non-ergot Dopamine Agonist For Parkinson's Disease
15 Jun 2008
GlaxoSmithKline announced the approval of Requip® XL™(ropinirole extended-release tablets) in the U.S. for the treatment of the signs and symptoms of idiopathic Parkinson's disease...


When Your Cycle Becomes a Major Headache
When Your Cycle Becomes a Major Headache

Cathy's gets as many as 12 to 15 headaches a month and they are all associated with her menstrual cycle. Migraines like hers tend to last longer and be more severe than other migraines. Figuring out what was triggering her headaches helped Cathy and her doctor come up with a successful treatment plan.

more videos are available in our health videos section.